Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Development (Cambridge, England)
|
July 15, 2011
Live imaging of the Drosophila spermatogonial stem cell niche reveals novel mechanisms regulating germline stem cell output
X Rebecca Sheng, Erika Matunis
Fly
|
November 20, 2009
Make room for dedifferentiation
X Rebecca Sheng, Erika L Matunis
Cell Stem Cell
|
August 12, 2009
Dedifferentiating spermatogonia outcompete somatic stem cells for niche occupancy in the Drosophila testis
X Rebecca Sheng, Crista M Brawley, Erika L Matunis
Journal of Pharmaceutical and Biomedical Analysis
|
September 1, 2024
Evaluation of low volume sampling devices for a pharmacodynamic biomarker analysis: Challenges and solutions
Xiaoyun Yang, Evelin Logis, Kathi Williams, et al.
Developmental Biology
|
August 1, 2009
Jak-STAT regulation of male germline stem cell establishment during Drosophila embryogenesis
X Rebecca Sheng, Trevor Posenau, Juliann J Gumulak-Smith, et al.
Neuroscience Research
|
April 29, 2006
Identification and functional significance of polymorphisms in the mu-opioid receptor gene (Oprm) promoter of C57BL/6 and DBA/2 mice
Glenn A Doyle, X Rebecca Sheng, Candice L Schwebel, et al.
Clinical Immunology (Orlando, Fla.)
|
July 21, 2023
Biomarkers of fibrosis, inflammation, and extracellular matrix in the phase 3 trial of tocilizumab in systemic sclerosis
X Rebecca Sheng, Xia Gao, Courtney Schiffman, et al.
Gene
|
April 3, 2007
Identification of five mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon
Glenn A Doyle, X Rebecca Sheng, Sharon S J Lin, et al.
Gene
|
December 13, 2006
Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon
Glenn A Doyle, X Rebecca Sheng, Sharon S J Lin, et al.
Rheumatology and Therapy
|
April 25, 2024
A Phase 1a Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7303509, an Anti-TGFβ3 Antibody, in Healthy Volunteers
Lyrialle W Han, Samira Jamalian, Joy C Hsu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Development (Cambridge, England)
|
July 15, 2011
Live imaging of the Drosophila spermatogonial stem cell niche reveals novel mechanisms regulating germline stem cell output
X Rebecca Sheng, Erika Matunis
Fly
|
November 20, 2009
Make room for dedifferentiation
X Rebecca Sheng, Erika L Matunis
Cell Stem Cell
|
August 12, 2009
Dedifferentiating spermatogonia outcompete somatic stem cells for niche occupancy in the Drosophila testis
X Rebecca Sheng, Crista M Brawley, Erika L Matunis
Journal of Pharmaceutical and Biomedical Analysis
|
September 1, 2024
Evaluation of low volume sampling devices for a pharmacodynamic biomarker analysis: Challenges and solutions
Xiaoyun Yang, Evelin Logis, Kathi Williams, et al.
Developmental Biology
|
August 1, 2009
Jak-STAT regulation of male germline stem cell establishment during Drosophila embryogenesis
X Rebecca Sheng, Trevor Posenau, Juliann J Gumulak-Smith, et al.
Neuroscience Research
|
April 29, 2006
Identification and functional significance of polymorphisms in the mu-opioid receptor gene (Oprm) promoter of C57BL/6 and DBA/2 mice
Glenn A Doyle, X Rebecca Sheng, Candice L Schwebel, et al.
Clinical Immunology (Orlando, Fla.)
|
July 21, 2023
Biomarkers of fibrosis, inflammation, and extracellular matrix in the phase 3 trial of tocilizumab in systemic sclerosis
X Rebecca Sheng, Xia Gao, Courtney Schiffman, et al.
Gene
|
April 3, 2007
Identification of five mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon
Glenn A Doyle, X Rebecca Sheng, Sharon S J Lin, et al.
Gene
|
December 13, 2006
Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon
Glenn A Doyle, X Rebecca Sheng, Sharon S J Lin, et al.
Rheumatology and Therapy
|
April 25, 2024
A Phase 1a Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7303509, an Anti-TGFβ3 Antibody, in Healthy Volunteers
Lyrialle W Han, Samira Jamalian, Joy C Hsu, et al.
Page
of 2